If you are an expert in the field of microbiome science, and work with the development of microbiome-based biomarkers, we need your valuable insight.

We are helping to coordinate an academia and industry-wide survey (using a tool known as a Delphi process) to move this important aspect of the field forward.

This will require a wide representation in the field so please feel free to share this information with your own network!

The aim of the European IHMCSA Human Microbiome Action WP6 Delphi survey is to assess the knowledge and perception of multiple stakeholders on two key points:

  1. The definition and qualification procedure of microbiome-based biomarkers
  2. The factors limiting the translation from discovery into qualification and clinical implementation of these microbiome-based biomarkers

This Delphi survey is part of the Human Microbiome Action Project.

If you would like to participate – click the button below, or send an email expressing your interest to delphi@pharmabiotic.org.

 

About the European IHMCSA Human Microbiome Action – https://humanmicrobiomeaction.eu/

Human Microbiome Action is an EU-funded Horizon 2020 project (grant agreement N° 964590) aiming to maximize the impact of European microbiome research and innovation to tackle the epidemics of chronic diseases.

At the core of the project’s mission is the ambition to create coherence and harmony in the ways microbiome research is and will be performed. By aligning, structuring and providing direction to EU microbiome research, the project will contribute to reach a health care system that takes into consideration the human microbiome.

The project will last for 3 years (2021-2024) and is coordinated by France’s National Research Institute for Agriculture, Food and Environment (INRAE).

Joseph Simmons

Operations Manager